GLIPIZIDE AND METFORMIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glipizide And Metformin Hydrochloride, and what generic alternatives are available?
Glipizide And Metformin Hydrochloride is a drug marketed by Dash Pharms, Epic Pharma Llc, Heritage Pharms, Sun Pharm Inds Inc, Teva Pharms, and Zydus Pharms Usa Inc. and is included in six NDAs.
The generic ingredient in GLIPIZIDE AND METFORMIN HYDROCHLORIDE is glipizide; metformin hydrochloride. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the glipizide; metformin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Glipizide And Metformin Hydrochloride
A generic version of GLIPIZIDE AND METFORMIN HYDROCHLORIDE was approved as glipizide; metformin hydrochloride by EPIC PHARMA LLC on October 27th, 2005.
Summary for GLIPIZIDE AND METFORMIN HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Clinical Trials: | 11 |
Patent Applications: | 10 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GLIPIZIDE AND METFORMIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for GLIPIZIDE AND METFORMIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Merck Sharp & Dohme Corp. | Phase 4 |
The Catholic University of Korea | Phase 4 |
John H. Stroger Hospital | Phase 4 |
See all GLIPIZIDE AND METFORMIN HYDROCHLORIDE clinical trials
Pharmacology for GLIPIZIDE AND METFORMIN HYDROCHLORIDE
Drug Class | Biguanide Sulfonylurea |